Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events "TRACE"

Not yet recruiting

Phase 2/3 Results N/A

Summary of Purpose

Transient ischemic attack (TIA) or minor ischemic stroke has a high risk of early recurrent stroke. As the golden standard, aspirin effect modestly on acute ischemic stroke, and slightly increase the risk of intracerebral hemorrhage. Recently, rivaroxaban, a new oral anticoagulant, is proved to be as effective as traditional anticoagulants, while carrying significantly less risk of intracranial hemorrhage. ...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 August 2013.

1 Sep 2013 19 Jul 2013 1 Sep 2015 1 Apr 2016 1 Aug 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment